TRACON Pharmaceuticals, Inc.
(NASDAQ : TCON)

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 0.10%125.140.0%$2517.24m
BNGOBioNano Genomics, Inc. -11.93%8.050.0%$1626.30m
GILDGilead Sciences, Inc. 1.37%67.991.0%$696.88m
AMGNAmgen, Inc. 1.65%252.361.3%$574.64m
CRSPCRISPR Therapeutics AG -4.30%189.770.6%$516.52m
REGNRegeneron Pharmaceuticals, Inc. 1.57%542.272.7%$477.27m
ALXNAlexion Pharmaceuticals, Inc. -0.61%157.742.0%$471.04m
NVAXNovavax, Inc. -2.31%125.0592.9%$463.88m
ILMNIllumina, Inc. 3.42%403.543.5%$395.72m
SRPTSarepta Therapeutics, Inc. -0.04%96.7613.8%$351.95m
VRTXVertex Pharmaceuticals, Inc. 2.07%236.701.9%$351.25m
BIIBBiogen, Inc. -1.30%270.281.7%$328.68m
BNTXBioNTech SE -1.40%103.230.0%$308.28m
OCGNOcugen, Inc. -4.70%2.230.0%$294.71m
PACBPacific Biosciences of California, Inc. -4.02%38.597.4%$258.16m

Company Profile

TRACON Pharmaceuticals, Inc. engages in the development and commercialization of targeted therapies for cancer, ophthalmic, and fibrotic diseases. Its products include TRC105, an anti-endoglin antibody for the treatment of solid tumor types; TRC205 created for the treatment of fibrotic diseases; and TRC102, a small molecule that is in clinical development made for lung cancer and glioblastoma. The company was founded in October 2004 and is headquartered in San Diego, CA.